UW Center for Tobacco Research and Intervention
Madison, Wisconsin, 53711, United States
NCT Number: NCT01621022
Focus of this study was to determine if bupropion was more effective for smoking cessation when used alone or combined with nicotine gum.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Madison, Wisconsin, 53711, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
150 mg bupropion twice daily plus 4 mg nicotine gum as needed (up to 12 pcs/day)
150mg bupropion twice daily plus placebo nicotine gum as needed (up to 12 pcs/day)
Placebo bupropion twice daily + placebo nicotine gum as needed (up to 12 pcs/day)
Time frame: 6 months
No smoking, not evan a puff, during the 7 days prior to the 6 month follow-up
University of Wisconsin, Madison
Other
Efficacy of Bupropion Alone and in Combination With Nicotine Gum
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00968513
Behavior, Chemically-Induced Disorders
Berkeley, California, United States
View Trial DetailsNCT05021185
Behavior, Cancer
San Francisco, California, United States
View Trial DetailsNCT04188197
Behavior, Chemically-Induced Disorders
Charlotte, North Carolina, United States
View Trial DetailsNCT03259360
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial Details